|
原文出处：
|
|
Li J, Olaleye OE, Yu X, et al. High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care ［J］. Acta Pharm Sin B, 2019, 9(5): 1035-1049.
|
|
其他参考文献：
|
| ［1］ |
Fugh-Berman A. Herb-drug interactions［J］. Lancet, 2000, 355(9198): 134-138.
|
| ［2］ |
Sparreboom A, Cox MC, Acharya MR, et al. Herbal remedies in the United States: potential adverse interactions with anticancer agents ［J］. J Clin Oncol, 2004, 22(12): 2489-2503.
|
| ［3］ |
Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases ［J］. J Am Coll Cardiol, 2010, 55(6): 515-525.
|
| ［4］ |
Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions ［J］. Planta Med, 2012, 78(13): 1458-1477.
|
| ［5］ |
Stieger B, Mahdi ZM, Jger W. Intestinal and hepatocellular transporters: therapeutic effects and drug interactions of herbal supplements ［J］. Annu Rev Pharmacol Toxicol, 2017, 57: 399-416.
|
| ［6］ |
Cheng C, Lin JZ, Li L, et al. Pharmacokinetics and disposition of monoterpene glycosides derived from Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic XueBiJing injection in human subjects and rats ［J］. Acta Pharmacol Sin, 2016, 37(4): 530-544.
|
| ［7］ |
Li XX, Cheng C, Wang FQ, et al. Pharmacokinetics of catechols in human subjects intravenously receiving XueBiJing injection, an emerging antiseptic herbal medicine ［J］. Drug Metab Pharmacokinet, 2016, 31(1): 95-98.
|
| ［8］ |
Zhang NT, Cheng C, Olaleye OE, et al. Pharmacokinetics-based identification of potential therapeutic phthalides from XueBiJing, a Chinese herbal injection used in sepsis management ［J］. Drug Metab Dispos, 2018, 46(6): 823-834.
|
| ［9］ |
Song YL, Yao C, Yao YM, et al. XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial ［J］. Crit Care Med, 2019, 47(9): e735-e743.
|
